Sign up to save your podcasts
Or
Share Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile
Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond.
Read the full article at: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00233-6/fulltext?dgcid=buzzsprout_icw_podcast_10-06-25_laninf
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
View all episodes
By The Lancet GroupLeonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond.
Read the full article at: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00233-6/fulltext?dgcid=buzzsprout_icw_podcast_10-06-25_laninf
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More shows like The Lancet Infectious Diseases in conversation with
View all
JAMA Editors' Summary
139 Listeners
6 Minute English
1,802 Listeners
This Week in Virology
2,057 Listeners
NEJM This Week
322 Listeners
JAMA Clinical Reviews
500 Listeners
The Curbsiders Internal Medicine Podcast
3,337 Listeners
The Daily
112,522 Listeners
Core IM | Internal Medicine Podcast
1,137 Listeners
Immune
268 Listeners
Annals On Call Podcast
192 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Breakpoints
159 Listeners
The Lancet Voice
22 Listeners
The Lancet Child & Adolescent Health in conversation with
0 Listeners
The Lancet Digital Health in conversation with
0 Listeners
The Lancet Global Health in conversation with
2 Listeners
The Lancet Oncology in conversation with
2 Listeners
The Lancet Psychiatry in conversation with
0 Listeners
The Lancet Respiratory Medicine in conversation with
1 Listeners
The Lancet in conversation with
0 Listeners
The Lancet Haematology in conversation with
0 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
The Lancet Diabetes & Endocrinology in conversation with
1 Listeners
The Lancet Public Health in conversation with
1 Listeners
The Lancet Microbe in conversation with
0 Listeners
In conversation with...
0 Listeners
eBioMedicine in conversation with
0 Listeners
ID:IOTS - Infectious Disease Insight Of Two Specialists
31 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
Infectious Disease Puscast
85 Listeners
The Lancet Regional Health in conversation with
0 Listeners
Communicable
3 Listeners
The Lancet Regional Health Americas in conversation with
0 Listeners
The Lancet Primary Care in conversation with
0 Listeners